Search

everythinglearnresearchcommunity

for

Search:↓

An imbalance in gut bacteria is linked to skin immune diseases and may affect their outcomes and related health issues.

Early balding, especially frontal, increases prostate cancer risk; more research needed.

Mesotherapy helps treat male hair loss effectively.

Toxoplasma gondii infection may increase testosterone levels in males.

PCOS often leads to sleep problems, especially obstructive sleep apnea, affecting overall health.

Longer anogenital distance may indicate a higher chance of having polycystic ovary syndrome, and measuring this distance along with hormone levels could improve diagnosis.

Long-haul COVID can cause lasting symptoms affecting many body systems and may be linked to ongoing inflammation and immune system issues.

Men with vertex baldness may have a higher risk of developing prostate cancer, but more research is needed to confirm this.

Polycystic ovary syndrome and iron overload share similar symptoms and can be potentially treated with blood removal, diet changes, and probiotics.

Certain metabolites can either protect against or increase the risk of hair loss.

Bariatric surgery can cause serious mineral deficiencies, requiring better patient education and monitoring.

PPAR-γ helps control skin oil glands and inflammation, and its disruption can cause hair loss diseases.

Women with PCOS may be more likely to have gum disease than healthy women.

Alopecia areata patients, especially women with nail issues or atopic diseases, are at higher risk for other autoimmune diseases.

The review concludes that pharmacists should clearly define their product as more than medication, including their knowledge and services, to effectively communicate their value.

Iron supplements may improve hair loss satisfaction even if initial iron levels are normal.

Tirzepatide might help manage PCOS in obese patients but needs more research to confirm safety and effectiveness.

Many patients experience long-lasting symptoms like fatigue and pain after COVID-19, regardless of initial disease severity.

COVID-19 can cause various skin issues, like rashes and lesions, which are more common in younger patients and can be linked to more severe complications.

Certain changes in the VEGF gene can increase or decrease the risk of polycystic ovary syndrome.

COVID-19 can cause hair loss in both severe and mild cases, often affecting women.

Lipid Accumulation Product and Free Androgens Index are effective for assessing fatty liver disease risk in women with Polycystic Ovary Syndrome.

Topical minoxidil is the best-supported treatment for female hair loss, but personalized plans are needed.

A married couple both developed a rare type of hair loss, possibly due to shared environmental factors.

Hormone replacement therapy may lower the risk of severe COVID-19 outcomes in non-immunosuppressed people and male organ transplant recipients.

People with androgenic alopecia (AGA) have a higher chance of getting metabolic syndrome.

Vitamin A deficiency changes cattle hair structure, while pregnancy may improve it, suggesting hair can indicate cattle health.

Finasteride's polymorphic form affects capsule quality and drug effect, requiring strict control.

Different hair loss treatment ingredients work well with TrichoTech™ vehicles for 3 to 6 months, making them good for use in hair treatments.

Laser treatment is safe and can effectively treat toenail fungus, especially when combined with other treatments if no improvement is seen after about a year.